A Revolutionary Non-Invasive Acquired Ptosis Treatment

Sep 10, 2021  

Columbia, S.C, September 10, 2021 — Acquired Ptosis affects many adults in the U.S. But don’t let low-lying lids get in the way of life. The Eye Center, P.A. now offers UPNEEQ as a solution for ptosis. This premiere eye surgery center in South Carolina is available to diagnose adult cases of ptosis and provide this state-of-the-art, non-invasive treatment.

UPNEEQ is a 0.1% ophthalmic solution of oxymetazoline hydrochloride, developed to be used as a treatment for acquired blepharoptosis. At this time it is the only FDA non-surgical treatment for this disorder. Providing eyelid restoration in the convenience of daily eye drops.

UPNEEQ is being offered in a modern and revolutionary way. The typical trials and tests of having to go through insurance protocols such as prior authorizations, step edits, or callbacks. This world-changing eyelid treatment is offered exclusively through RVL Pharmacy. Making it easily attainable for all who need it.

A 30-day dose is a $105 flat. No hidden fees or copays are involved. In fact, Upneeq provider, RVL Pharmacy does not require or accept insurance. Allowing them to expand the access of their product to all who are in medical need of it.

The decision to pursue UPNEEQ as a non-surgical alternative to acquired adult blepharoptosis should be carefully considered between the patient and skilled ophthalmologist. Be sure to disclaim full medical history so qualified medical professionals can assess all risks and benefits of this treatment route.

The Eye Center, P.A. has ophthalmologists on staff ready and available to diagnose and prescribe ptosis treatment, today. Check out theeyecentersc.com or call 803-256-0641 to make an appointment or speak to a medical professional.

About Author
The Eye Center is the leading refractive practice in South Carolina, providing full-service eye care and specializing in Refractive Surgery – Lasik, AST, PRK, PRELEX, as well as Corneal Transplant and Cataract Surgery.


AcrySofⓇ IQ PanOptixⓇ IOL
Provides cataract patients with clear vision for near, intermediate and far distances, without glasses.
AcrySofⓇ IQ PanOptixⓇ IOL

Glaucoma & iStent
iStent works to help control your eye pressure by improving the outflow of fluid from your eyes.

Diabetic Eye Disease
Diabetic eye disease is the leading cause of blindness in the 20-64 year age group.
Diabetic Retinopathy

LenSx® Femtosecond Laser
The LenSx® Laser is the first femtosecond laser cleared by the FDA for use in cataract surgery.
LenSx® Femtosecond Laser